Valuation Sino Biopharmaceutical Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 01:14:06 15/06/2026 pm IST			5-day change	1st Jan Change
4.790 ^HKD	+1.91%		+5.74%	-22.49%

06:53am	Sino Biopharmaceutical Plans HK$2 Billion Stock Buyback	MT
30/05	Sino Biopharmaceutical Limited Announces Approval For Marketing of Naldemedine For Opioid-Induced Constipation In Adults	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	83,429	74,710	57,953	54,744	99,279	72,375	-	-
Change	-	-10.45%	-22.43%	-5.54%	81.35%	-27.1%	-	-
Enterprise Value (EV) ¹	80,322	72,794	60,695	54,757	1,03,077	67,661	62,231	56,064
Change	-	-9.37%	-16.62%	-9.78%	88.24%	-34.36%	-8.03%	-9.91%
P/E Ratio	6.07x	33.3x	25x	15.7x	42.8x	17.6x	16.2x	14.7x
PBR	2.76x	2.51x	1.94x	1.77x	3.4x	2.18x	1.98x	1.79x
PEG	-	-0.4x	6.9x	0.3x	-1.3x	0.2x	1.84x	1.51x
Capitalization / Revenue	3.11x	2.6x	2.21x	1.9x	3.12x	2.01x	1.85x	1.67x
EV / Revenue	2.99x	2.53x	2.32x	1.9x	3.24x	1.88x	1.59x	1.29x
EV / EBITDA	15.5x	10.5x	9.37x	8.44x	13.9x	7.24x	6.18x	5.04x
EV / EBIT	19.2x	12.4x	11.2x	10.6x	16.6x	8.2x	6.97x	5.65x
EV / FCF	21.1x	16.2x	17.7x	14.2x	12.7x	10.1x	7.64x	6.79x
FCF Yield	4.74%	6.19%	5.64%	7.05%	7.86%	9.86%	13.1%	14.7%
Dividend per Share ²	0.0648	0.105	0.0462	0.0653	0.0883	0.0815	0.0884	0.0816
Rate of return	1.46%	2.6%	1.47%	2.17%	1.59%	2.01%	2.18%	2.01%
EPS ²	0.7326	0.1215	0.1259	0.1913	0.1298	0.2308	0.2511	0.2756
Distribution rate	8.84%	86.4%	36.7%	34.1%	68%	35.3%	35.2%	29.6%
Net sales ¹	26,861	28,780	26,199	28,866	31,834	36,035	39,093	43,417
EBITDA ¹	5,174	6,908	6,476	6,490	7,431	9,341	10,064	11,121
EBIT ¹	4,182	5,861	5,439	5,169	6,219	8,256	8,925	9,918
Net income ¹	14,608	2,544	2,332	3,500	2,343	4,026	4,439	4,819
Net Debt ¹	-3,107	-1,915	2,742	12.99	3,799	-4,714	-10,144	-16,311
Reference price ²	4.448	4.042	3.150	3.007	5.554	4.059	4.059	4.059
Nbr of stocks (in thousands)	1,87,56,114	1,84,81,249	1,83,99,239	1,82,05,469	1,78,76,722	1,78,31,212	-	-
Announcement Date	31/03/22	31/03/23	28/03/24	20/03/25	26/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SINO BIOPHARMACEUTICAL LIMITED	17.59x	1.88x	7.24x	2.01%	1.07TCr
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,01000Cr
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	58TCr
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	40TCr
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	33TCr
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	28TCr
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	28TCr
NOVO NORDISK A/S	12.7x	4.75x	9.72x	3.95%	20TCr
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	19TCr
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	16TCr
Average	15.69x	5.76x	15.00x	2.5%	34.39TCr
Weighted average by Cap.	22.66x	7.46x	17.38x	2.09%